| Literature DB >> 25017919 |
Jason S Bradfield1, Marmar Vaseghi1, Kalyanam Shivkumar2.
Abstract
The autonomic nervous system is known to play a significant role in the genesis and persistence of arrhythmias. Neuromodulation has become a new therapeutic strategy for the treatment of ventricular arrhythmias. Catheter-based renal denervation (RDN) is being studied as a treatment option for drug-refractory hypertension. Ablation within the renal arteries, by altering efferent and afferent signaling, has the potential to improve blood pressure, as well as heart failure, atrial, and ventricular tachyarrhythmias. We present a brief review of the anatomic and pathophysiological rationale for RDN as an adjunctive treatment for ventricular tachyarrhythmias. Published by Elsevier Inc.Entities:
Mesh:
Year: 2014 PMID: 25017919 PMCID: PMC4254550 DOI: 10.1016/j.tcm.2014.05.006
Source DB: PubMed Journal: Trends Cardiovasc Med ISSN: 1050-1738 Impact factor: 6.677